The historic rise of Viagra has firmly established as a example of pharmaceutical success, yet its legacy within the broader industry now presents questions about future returns . Generic versions are diminishing exclusivity , prompting concerns that investing in companies significantly dependent to Viagra's once-dominant standing could be a proble